Evidence map›Paper›PMID 35071827›Full record

ArticleAdvances in radiation oncology

A Safe and Practical Cycle for Team-Based Development and Implementation of In-House Clinical Software.

Jean M Moran, Kelly C Paradis, Scott W Hadley, Martha M Matuszak, Charles S Mayo, Katherine Woch Naheedy, Xiaoping Chen, Dale W Litzenberg, James Irrer, Maria G Ditman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Survey in radiation oncology departments in Germany, Austria, and Switzerland: state of digitalization by 2023.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jean M MoranDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Kelly C ParadisDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Scott W HadleyDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Martha M MatuszakDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Charles S MayoDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Katherine Woch NaheedyDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Xiaoping ChenDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Dale W LitzenbergDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
James IrrerDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Maria G DitmanDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Pam BurgerDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Marc L KesslerDepartment of Radiation Oncology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
Michigan Medicine · US

Funding

TREATMENT VERIFICATION AND TREATMENT PLAN REFINEMENTP01CA059827 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KESSLER, MARC LEWIS, LAWRENCE, THEODORE S · 1993 to 2018
$37.9M
NCI NIH HHS P01 CA059827
6 · The paper itself

Abstract

purposeDue to a gap in published guidance, we describe our robust cycle of in-house clinical software development and implementation, which has been used for years to facilitate the safe treatment of all patients in our clinics. METHODS AND MATERIALS: Our software development and implementation cycle requires clarity in communication, clearly defined roles, thorough commissioning, and regular feedback. Cycle phases include design requirements and use cases, development, physics evaluation testing, clinical evaluation testing, and full clinical release. Software requirements, release notes, test suites, and a commissioning report are created and independently reviewed before clinical use. Software deemed to be high-risk, such as those that are writable to a database, incorporate the use of a formal, team-based hazard analysis. Incident learning is used to both guide initial development and improvements as well as to monitor the safe use of the software.

resultsOur standard process builds in transparency and establishes high expectations in the development and use of custom software to support patient care. Since moving to a commercial planning system platform in 2013, we have applied our team-based software release process to 16 programs related to scripting in the treatment planning system for the clinic.

conclusionsThe principles and methodology described here can be implemented in a range of practice settings regardless of whether or not dedicated resources are available for software development. In addition to teamwork with defined roles, documentation, and use of incident learning, we strongly recommend having a written policy on the process, using phased testing, and incorporating independent oversight and approval before use for patient care. This rigorous process ensures continuous monitoring for and mitigatation of any high risk hazards.

Identifiers

PMID35071827
PMCPMC8767245
OpenAlexW3201360815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.